NexPoint Residential Trust Inc
Change company Symbol lookup
Select an option...
NXRT NexPoint Residential Trust Inc
WTR Aqua America Inc
GOOG Alphabet Inc
BBL BHP Group PLC
NOK Nokia Oyj
LMAT LeMaitre Vascular Inc
CXW CoreCivic Inc
SITE SiteOne Landscape Supply Inc
NVDA NVIDIA Corp
BAC Bank of America Corp
Go

Real Estate : Equity Real Estate Investment Trusts (REITs) | Company profile

NexPoint Residential Trust, Inc. is an externally managed real estate investment trust (REIT). The Company's investment objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions and achieve long-term capital appreciation for its stockholders through targeted management and a value-add program. The Company is focused on multifamily investments primarily located in the Southeastern and Southwestern United States. All of the Company's business operations are conducted through NexPoint Residential Trust Operating Partnership, L.P. (OP). The sole limited partner of the OP is the Company. Its subsidiary, NexPoint Residential Trust Operating Partnership GP, LLC, is the sole general partner of the OP. As of December 31, 2016, the Company owned 39 properties representing 12,965 units in eight states, including two Parked Assets. The Company's advisor is NexPoint Real Estate Advisors, L.P.

Closing Price
$38.37
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
70,396
0

UPDATE: Cannabis earnings: Pot stocks' downturn may drown Aurora and others in red ink

8:47 am ET February 11, 2019 (MarketWatch)
Print

By Max A. Cherney

Canadian producers like Aurora Cannabis and Canopy Growth could show losses from decline in investments in other companies

With Aurora Cannabis Inc. and Canopy Growth Corp. reporting earnings in the coming days, investors should watch closely for losses due to their investments in other weed companies.

Recreational cannabis legalization began Oct. 17 in Canada (http://www.marketwatch.com/story/cannabis-is-now-legal-in-canada-but-pot-companies-expect-a-rocky-start-2018-10-17), and despite the federal government's public statements (http://www.marketwatch.com/story/canadian-minister-of-pot-cannabis-inventory-sufficient-to-meet-demand-2019-01-30), in the intervening months, the country is grappling with massive supply shortages (http://www.marketwatch.com/story/canadas-pot-party-big-demand-short-supply-and-stamps-with-no-glue-2018-10-20), according multiple people running companies or working in the sector. Provinces have blamed the licensed cannabis producers (https://www.marketwatch.com/story/canadas-struggle-to-supply-legal-weed-) for the lack of available product, yet the weed producers have said that the shortage and weak September-quarter earnings (http://www.marketwatch.com/story/pot-companies-still-working-out-the-supply-kinks-to-meet-strong-canadian-demand-2018-11-17) are a result of licensing backlogs and provincial buyers placing small orders.

The uncertainty surrounding early returns and supply-chain difficulties have weighed on pot stocks, along with doubts about their outsize valuations.

Don't miss: How marijuana companies will report profit despite not selling pot (http://www.marketwatch.com/story/how-marijuana-companies-can-profit-without-selling-pot-2019-02-08)

Since Oct. 17, ETFMG Alternative Harvest ETF (MJ) has dropped 11%, Horizons Marijuana Life Sciences Index ETF has fallen 14%. After a more than 600% gain on its stock since going public, Tilray Inc. dropped about 40%, Canopy Growth (WEED.T) (WEED.T)has fallen 9.8%. Unlike many of its rivals, Cronos Group Inc. (CRON.T)(CRON.T) has performed well, nearly doubling after it announced that Altria Group Inc. (MO) had taken a $1.8 billion stake in the company.

The downturn could be a problem for Aurora (ACB.T) , (ACB.T) especially, which has said it expects sales of C$50 to C$55 million (http://www.marketwatch.com/press-release/aurora-cannabis-provides-guidance-for-the-second-quarter-of-fiscal-2019-anticipating-net-revenues-of-50m-to-55m-2019-01-08) ($37.6 million to $41.4 million) and reports Monday after the opening bell. While Aurora's portfolio of pot stocks generated large profit (http://www.marketwatch.com/story/aurora-stock-falls-as-earnings-show-cannabis-companys-investments-are-still-the-big-earners-2018-11-12) in September-quarter results, it could report massive losses this time around because of the sector's descent and its specific holdings.

For more: Cronos CEO says $1.8 billion from Big Tobacco is just a beginning for cannabis industry (http://www.marketwatch.com/story/cronos-ceo-says-altria-investment-is-just-the-beginning-2018-12-07)

Cronos aside, the pot stock drop is going to be a especially serious for Aurora, because one of the company's largest investments is in Green Organic Dutchman Holdings Ltd. (TGOD.T) , which gave up its gains from earlier in the year while losing roughly 40% of its value. In a note published late Thursday, Harvest Moon Cannabis Co. CEO Robert Doxtator wrote that he estimates Aurora's portfolio losses (http://harvestmooncannabis.ca/aurora.pdf) at C$425 million for the December quarter.

But the losses will be "on paper" losses and don't directly affect Aurora -- and others' -- ability to produce and sell pot.

Analysts polled by FactSet on average project losses of C$0.6 cents a share on sales of C$51.8 million for Aurora. Note there are only two analysts contributing those estimates, which can make the consensus unreliable. Overall, six analysts cover Aurora with an average target price of C$12.09 a share, which represents a 21% upside from Thursday's closing price. Four have a buy rating, one rates it a hold and one analyst has a sell rating.

Explainomics: Investing in a cannabis company? Make sure to ask these four questions (http://www.marketwatch.com/story/how-marijuana-companies-can-profit-without-selling-pot-2019-02-08)

Canopy Growth, the world's largest pot company by market value, reports Thursday after the close. Canopy's profits may also suffer from the overall sector decline, since it holds a substantial portfolio of public companies, as does its publicly traded venture-capital arm, Canopy Rivers Inc.(RIV.V)

Analysts expect Canopy Growth to report losses of C$0.17 a share on sales of C$84.7 million, according to FactSet. Ten analysts cover the name, nine of which have a buy rating; one rates Canopy a sell. The average price target is C$70.70, which is a 17% upside from Thursday's closing price.

The considerably smaller Supreme Cannabis Co. Inc. (FIRE.V) will report Tuesday before the open. Tilray and Cronos have not announced their earnings dates.

Aphria Inc. (APHA.T)(APHA.T) , which is the target of a hostile takeover bid (http://www.marketwatch.com/story/the-aphria-hostile-takeover-offer-is-littered-with-red-flags-2018-12-28), and Organigram Holdings Inc. (OGI.V) reported results (http://www.marketwatch.com/story/marijuana-stocks-rise-after-organigram-doubles-revenue-forecast-2019-01-28) in January.

-Max A. Cherney; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

February 11, 2019 08:47 ET (13:47 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.